Ireland-based healthcare technology company Medtronic has announced an agreement to acquire EOFlow, a South Korean medical device company, for a total consideration of KRW 971 billion ($738 million). This acquisition marks Medtronic’s move to expand its capabilities in addressing the needs of individuals with diabetes. South Korean medical device innovation in diabetes care Founded in […]
Eli Lilly and Company (Lilly) has agreed to sell its severe hypoglycemia drug BAQSIMI to Amphastar Pharmaceuticals in a deal potentially worth up to $1.07 billion. BAQSIMI is indicated for the treatment of severe hypoglycemia, which is very low blood sugar, in people with diabetes aged four years and over. It is the first as […]
Mylan and Biocon have secured approval from the US Food and Drug Administration (FDA) for Semglee (insulin glargine injection) in vial and pre-filled pen presentations to regulate high blood sugar in adults with type 2 diabetes and adult and pediatric patients with type 1 diabetes. According to Mylan, Semglee has an identical amino acid sequence […]